申请人:——
公开号:US20040142933A1
公开(公告)日:2004-07-22
This invention relates to compounds of the formula I
1
wherein Ar, A, R, R
1
, R
2
, R
3
, R
4
and R
5
are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
本发明涉及公式I1的化合物,其中Ar、A、R、R1、R2、R3、R4和R5的定义如规范中所述,包含它们的药物组合物以及它们在治疗中枢神经系统疾病中的应用。